Agios to Present at the TD Cowen 45th Annual Healthcare Conference on March 3, 2025

Core Insights - Agios Pharmaceuticals is scheduled to present at the TD Cowen 45th Annual Healthcare Conference on March 3, 2025, at 10:30 a.m. ET [1] - The presentation will be accessible via a live webcast on the company's website, with a replay available for at least two weeks [2] Company Overview - Agios Pharmaceuticals is a leader in pyruvate kinase (PK) activation, focusing on therapies for rare diseases [3] - The company markets a first-in-class PK activator for adults with PK deficiency, representing the first disease-modifying therapy for this condition [3] - Agios has a robust clinical pipeline targeting various conditions, including alpha- and beta-thalassemia, sickle cell disease, pediatric PK deficiency, myelodysplastic syndromes-associated anemia, and phenylketonuria [3] - Additionally, Agios is advancing a preclinical TMPRSS6 siRNA as a potential treatment for polycythemia vera [3]